register

News & Trends - MedTech & Diagnostics

Insurer premium reform critical to sustain private health sector

Health Industry Hub | June 28, 2024 |

MedTech & Diagnostics News: The annual private health insurance premium round process must be significantly reformed to protect private healthcare access for patients as funding issues continue to threaten services.

In a submission to the federal government, Catholic Health Australia called for several reforms, including directly linking annual premium increases with returns to patients and hospitals.

Funders with the lowest returns to patients and hospitals would only qualify for a limited increase in premiums while those with the highest returns would qualify for the maximum increase.

“In the past five years many insurers have been banking significant profits while returning less and less to patients and hospitals,” said Dr Katharine Bassett, CHA Director of Health Policy.

“This funding imbalance has contributed to the closure of 71 private hospital services across the sector in the past five years — and more will follow if we don’t pursue urgent reform.

“Linking premium increases with member benefits will ensure that highly profitable health funds have their members’ interests front and centre — and improve funding flows to patients and services,” she emphasised.

Last year insurers collectively returned just 83% of premiums to members and some major funds returned less than 80%, demonstrating the industry is failing to meet its own gold standard of returning 90% of premiums to patients.

CHA is also calling for a formalised approach to incorporating hospital cost data into the premium round process, and for the process to be entrusted to an independent body such as the Independent Health and Aged Care Pricing Authority.

“An independent body would take into account the evidence and data across the sector to deliver better outcomes for patients, hospitals, and funders,” said Dr Bassett.

She further added, “While delivering a more robust premium round in the short-term, this would also lay the groundwork for a careful and considered longer-term move towards a National Private Price — an independently set, nationally consistent activity-based funding model for private hospitals.

“The private sector plays a crucial role in alleviating pressure on public hospitals. The government’s current financial health check is a critical first step to funding reform that will ensure access, value, and choice for patients while supporting the viability of private hospitals. CHA looks forward to working collaboratively with this sector on this important initiative.”

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the ONLY one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The exclusive leadership and influencer podcasts and vodcasts add huge value to our breaking news coverage. The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. Please click here to subscribe and visit T&Cs here.


Communication

Australians trust in mainstream health media is in crisis

Australians’ trust in mainstream health media is in crisis

Health Industry Hub | July 1, 2024 |

Despite several mainstream media journalists being recognised at the 2024 Excellence in Health Journalism Awards by Rare Cancers and Prospection […]

More


News & Trends - Pharmaceuticals

New immunisation strategy sparks debate as vaccination rates decline

New immunisation strategy sparks debate as vaccination rates decline

Health Industry Hub | July 1, 2024 |

Pharma News: A new strategy is set to guide the nation’s immunisation efforts over the next five years, responding to […]

More


News & Trends - Pharmaceuticals

PBS listed - First oral targeted therapy in HER2-negative early breast cancer

PBS listed: First oral targeted therapy in HER2-negative early breast cancer

Health Industry Hub | July 1, 2024 |

Pharma News: A new targeted therapy is now accessible to Australians with an inherited form of high-risk, early breast cancer, […]

More


News & Trends - Pharmaceuticals

Sanofi's meningococcal vaccine enters National Immunisation Program amid market disruption

Sanofi’s meningococcal vaccine enters National Immunisation Program amid market disruption

Health Industry Hub | July 1, 2024 |

Pharma News: Sanofi’s meningococcal vaccine, MenQuadfi, will soon be available for free to adolescents as part of the National Immunisation […]

More


This content is copyright protected. Please subscribe to gain access.